DARE logo

Dare Bioscience (DARE)

Profile

Full Name

Daré Bioscience, Inc.

Ticker Symbol

DARE

Exchange

NASDAQ

Country

United States

IPO

April 10, 2014

Indexes

Not included

Employees

21

Key Details

Price

$2.90(-0.52%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9800.00(-99.65% YoY)

Annual EPS

-$0.48(+88.43% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 1, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Aug 16, 24 Jones Trading
Buy
Aug 14, 24 Maxim Group
Hold
May 15, 24 HC Wainwright & Co.
Buy
May 15, 24 Brookline Capital
Buy
May 1, 24 HC Wainwright & Co.
Buy
Apr 17, 24 Brookline Capital
Hold

Institutional Ownership

  • What is the ticker symbol for Dare Bioscience?
  • Does Dare Bioscience pay dividends?
  • What sector is Dare Bioscience in?
  • What industry is Dare Bioscience in?
  • What country is Dare Bioscience based in?
  • When did Dare Bioscience go public?
  • Is Dare Bioscience in the S&P 500?
  • Is Dare Bioscience in the NASDAQ 100?
  • Is Dare Bioscience in the Dow Jones?
  • When was Dare Bioscience's last earnings report?
  • When does Dare Bioscience report earnings?
  • Should I buy Dare Bioscience stock now?

What is the ticker symbol for Dare Bioscience?

The ticker symbol for Dare Bioscience is NASDAQ:DARE

Does Dare Bioscience pay dividends?

No, Dare Bioscience does not pay dividends

What sector is Dare Bioscience in?

Dare Bioscience is in the Healthcare sector

What industry is Dare Bioscience in?

Dare Bioscience is in the Biotechnology industry

What country is Dare Bioscience based in?

Dare Bioscience is headquartered in United States

When did Dare Bioscience go public?

Dare Bioscience's initial public offering (IPO) was on April 10, 2014

Is Dare Bioscience in the S&P 500?

No, Dare Bioscience is not included in the S&P 500 index

Is Dare Bioscience in the NASDAQ 100?

No, Dare Bioscience is not included in the NASDAQ 100 index

Is Dare Bioscience in the Dow Jones?

No, Dare Bioscience is not included in the Dow Jones index

When was Dare Bioscience's last earnings report?

Dare Bioscience's most recent earnings report was on Mar 31, 2025

When does Dare Bioscience report earnings?

The next expected earnings date for Dare Bioscience is May 14, 2025

Should I buy Dare Bioscience stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page